Korea Consumer Agency: Over Half Who Changed Meds Without Doctor on AI Advice Had Adverse Effects
Only 30.0% of adults who used artificial intelligence for pharmaceutical guidance verified the automated advice with a medical professional, according to a recent survey of 500 people by the Korea Consumer Agency.
The case of a 30-year-old man in South Korea who recently had severe abdominal pain and diarrhea showed the dangers of relying on unverified digital diagnostics. Seeking help, he consulted a generative AI tool for medical advice.
As the man followed the digital guidance, his condition worsened over time until hospital tests revealed a severe medical diagnosis.
The survey findings reveal broader risks across the public. A total of 22.0% of respondents stopped or changed their existing medications based solely on AI information without consulting a medical professional.
More than half of those who altered their regimens experienced adverse reactions, including worsening conditions or abnormal side effects.
Artificial intelligence tools often fail to account for critical personal health factors such as age, underlying medical conditions, and current prescriptions.
Some generative AI services also directed users to purchase channels for unauthorized pharmaceutical products, providing instructions for online purchasing agencies.
Unverified overseas direct-purchase items carry risks of forgery and alteration, according to the agency report.
“AI answers should be used only as a reference and should not be accepted as verified medical diagnosis or prescription,” the Korea Consumer Agency said.
“Matters such as stopping or changing medications being taken must be consulted with a doctor or pharmacist, and online sales, brokerage, and advertising of pharmaceuticals are illegal and must not be used,” an agency official told m.news.nate.com.